Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease : NeuroReport

Journal Logo

Neuropharmacology and Neurotoxicology

Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease

Caronti, Brunella1; Tanda, Gianluigi2; Colosimo, Carlo1; Ruggieri, Stefano3; Calderaro, Caterina1; Palladini, Guido1; Pontieri, Francesco E.1,4; Chiara, Gaetano Di2

Author Information

Abstract

THE early clinical symptoms of Parkinson's disease (PD) may be difficult to perceive and are frequently overlooked. Thus, interest has focused on the identification of biological or instrumental markers that may contribute to the early diagnosis of PD, with the aim of introducing neuroprotective therapies at the very start of illness. Impairment of nigrostriatal dopamine transmission can be visualized in vivo by functional imaging techniques, but these are rather complex and expensive examinations, available only in selected institutions. Here we show that dopamine content and tyrosine hydroxylase immunoreactivity are reduced in peripheral blood lymphocytes (PBL) in the early stages of PD. These data suggest that PBL may represent a simple and useful tool with which to identify precociously dopamine impairment in PD.

© 1999 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid